NeuBase Therapeutics (NASDAQ:NBSE – Get Rating) and Pyxis Oncology (NASDAQ:PYXS – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability. Insider and Institutional Ownership 37.2% of NeuBase Therapeutics shares […]